Analytical Data
-
Gene name
Avpr1b
- Application
-
Alternative Names
AVPR V1bAVPR V3Antidiuretic hormone receptor 1bVasopressin V3 receptor
-
Species
Rat
-
Source
E. coli
-
Tag
N- His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P48974
-
Expression Region
343-425aa
-
Molecular Weight
13 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Avpr1b, or the arginine vasopressin receptor 1B, is a G protein-coupled receptor that plays a crucial role in the regulation of stress response, behavior, and various physiological processes. Research surrounding Avpr1b has gained momentum due to its involvement in neuroendocrine functions and its association with psychiatric disorders such as anxiety and depression. As a key player in the hypothalamic-pituitary-adrenal (HPA) axis, Avpr1b mediates the effects of vasopressin on the release of adrenocorticotropic hormone (ACTH), influencing stress-related behaviors and endocrine responses. Recombination of Avpr1b protein has become a focal point in studies aimed at elucidating its structure-function relationships, binding affinities, and signaling pathways. Moreover, understanding the molecular dynamics of Avpr1b through recombinant techniques could pave the way for novel therapeutic interventions targeting stress-related disorders. Investigating Avpr1b’s interactions within the central nervous system and its ligand-binding characteristics is essential for developing strategies to modulate its activity, potentially leading to better management options for anxiety and other stress-related conditions. Given its crucial physiological roles and implications in mental health, the study of recombinant Avpr1b protein is vital for advancing our comprehension of neurobiology and influencing the future of psychopharmacological therapies.
